Literature DB >> 23948433

Identification and functional implication of nuclear localization signals in the N-terminal domain of JMJD5.

Xiaobin Huang1, Lingna Zhang, Hongyan Qi, Jimin Shao, Jing Shen.   

Abstract

JMJD5 has recently been reported to participate in circadian rhythm regulation, embryological development, osteoclastogenesis and tumorigenesis. Although JMJD5 has been found mainly localized in the nucleus of cells, how it enters the nucleus remains unclear. Here we report that JMJD5 contains a functional bipartite nuclear localization signal (NLS) and a chromosome region maintenance 1 (CRM1)-dependent nuclear export signal (NES). Importin α/β and transportin-1 were further identified as JMJD5-associated transport proteins, and different binding regions were determined for the two nuclear import receptors. Additionally, we demonstrate that both the active NLS and the JmjC domain of JMJD5 are necessary for cyclin A1 transcription. Chromatin immunoprecipitation (ChIP) analysis confirmed the alterations of di-methylated lysine 36 of histone H3 (H3K36me2) in the coding region of cyclin A1. These results reveal that the N-terminal domain is essential for the nuclear localization of JMJD5 and its normal enzymatic function towards substrates in the nucleus.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  JMJD5; Nuclear export signal; Nuclear localization signal; Transportin

Mesh:

Substances:

Year:  2013        PMID: 23948433     DOI: 10.1016/j.biochi.2013.08.002

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

Review 1.  The small members of the JMJD protein family: Enzymatic jewels or jinxes?

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

2.  JMJD5 (Jumonji Domain-containing 5) Associates with Spindle Microtubules and Is Required for Proper Mitosis.

Authors:  Zhimin He; Junyu Wu; Xiaonan Su; Ye Zhang; Lixia Pan; Huimin Wei; Qiang Fang; Haitao Li; Da-Liang Wang; Fang-Lin Sun
Journal:  J Biol Chem       Date:  2015-12-28       Impact factor: 5.157

3.  JMJD5 cleaves monomethylated histone H3 N-tail under DNA damaging stress.

Authors:  Jing Shen; Xueping Xiang; Lihan Chen; Haiyi Wang; Li Wu; Yanyun Sun; Li Ma; Xiuting Gu; Hong Liu; Lishun Wang; Ying-Nian Yu; Jimin Shao; Chao Huang; Y Eugene Chin
Journal:  EMBO Rep       Date:  2017-10-05       Impact factor: 8.807

4.  Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.

Authors:  Junyu Wu; Zhimin He; Da-Liang Wang; Fang-Lin Sun
Journal:  Cell Cycle       Date:  2016-10-07       Impact factor: 4.534

5.  JMJD-5/KDM8 regulates H3K36me2 and is required for late steps of homologous recombination and genome integrity.

Authors:  Pier Giorgio Amendola; Nico Zaghet; João J Ramalho; Jens Vilstrup Johansen; Mike Boxem; Anna Elisabetta Salcini
Journal:  PLoS Genet       Date:  2017-02-16       Impact factor: 5.917

6.  Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation.

Authors:  Tsan-Jan Chen; Hung-Jung Wang; Jai-Shin Liu; Hsin-Hung Cheng; Sheng-Chieh Hsu; Meng-Chen Wu; Chien-Hung Lu; Yu-Fang Wu; Jing-Wen Wu; Ying-Yuan Liu; Hsing-Jien Kung; Wen-Ching Wang
Journal:  Commun Biol       Date:  2019-03-15

Review 7.  JMJD family proteins in cancer and inflammation.

Authors:  Wang Manni; Xue Jianxin; Hong Weiqi; Chen Siyuan; Shi Huashan
Journal:  Signal Transduct Target Ther       Date:  2022-09-01

8.  KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC.

Authors:  Hung-Jung Wang; Mamata Pochampalli; Ling-Yu Wang; June X Zou; Pei-Shan Li; Sheng-Chieh Hsu; Bi-Juan Wang; Shih-Han Huang; Ping Yang; Joy C Yang; Cheng-Ying Chu; Chia-Ling Hsieh; Shian-Ying Sung; Chien-Feng Li; Clifford G Tepper; David K Ann; Allen C Gao; Christopher P Evans; Yoshihiro Izumiya; Chi-Pin Chuu; Wen-Ching Wang; Hong-Wu Chen; Hsing-Jien Kung
Journal:  Oncogene       Date:  2018-08-02       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.